AMBALALSA - Ambalal Sarabhai Enterprises Limited
BSE
->
Healthcare
->
Drug Manufacturers—General
Ahmedabad,
India
Type: Equity
AMBALALSA price evolution
AMBALALSA
| (in millions $) | 29 Jun 2020 | 30 Mar 2020 | 30 Dec 2019 | 29 Sep 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $127.88 | $240.67 | ||
| Short term investments | $170.69 | |||
| Net receivables | $378.97 | $293.62 | ||
| Inventory | $164.47 | $160.71 | ||
| Total current assets | $1039.68 | $1157.62 | ||
| Long term investments | $181.22 | $185.61 | ||
| Property, plant & equipment | $332.89 | $593.48 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1864.5 | $2248.23 | ||
| Current liabilities | ||||
| Accounts payable | $400.22 | $415.14 | ||
| Deferred revenue | ||||
| Short long term debt | $17.93 | |||
| Total current liabilities | $1334.65 | $1838.31 | ||
| Long term debt | $45.41 | $64.01 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1416.91 | $1938.43 | ||
| Shareholders' equity | ||||
| Retained earnings | -$426.8 | |||
| Other shareholder equity | $2.05 | -$456.49 | ||
| Total shareholder equity | $447.67 | $447.67 | $309.85 | $309.85 |
| (in millions $) | 30 Mar 2020 | 30 Mar 2019 | 30 Mar 2018 | 30 Mar 2017 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $127.88 | $169.95 | $135.07 | $54.06 |
| Short term investments | $158.26 | $0.03 | ||
| Net receivables | $378.97 | $498.82 | $569.28 | $334.77 |
| Inventory | $164.47 | $149.85 | $143.94 | $138.1 |
| Total current assets | $1039.68 | $1162.62 | $1135.5 | $732.48 |
| Long term investments | $181.22 | $93.57 | $54.27 | $48.76 |
| Property, plant & equipment | $332.89 | $570.95 | $482.04 | $508.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1864.5 | $2144.93 | $2002.54 | $1636.24 |
| Current liabilities | ||||
| Accounts payable | $400.22 | $468.3 | $397.56 | $291.43 |
| Deferred revenue | ||||
| Short long term debt | $17.93 | $27.4 | $17.53 | $14.78 |
| Total current liabilities | $1334.65 | $1713.21 | $1554.41 | $1244.29 |
| Long term debt | $45.41 | $87.59 | $111.22 | $51.1 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1416.91 | $1838.76 | $1737.39 | $1384.53 |
| Shareholders' equity | ||||
| Retained earnings | -$426.8 | -$567.63 | -$607.2 | -$621.13 |
| Other shareholder equity | $2.05 | $1.43 | -$0.06 | $0.43 |
| Total shareholder equity | $447.67 | $306.23 | $265.17 | $251.72 |
| (in millions $) | 29 Jun 2020 | 30 Mar 2020 | 30 Dec 2019 | 29 Sep 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $267.21 | $385.61 | $317.14 | $322.75 |
| Cost of revenue | $154.24 | $232.55 | $188.27 | $193.13 |
| Gross Profit | $112.98 | $153.06 | $128.87 | $129.62 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $64.69 | $84.17 | $65.66 | $63.42 |
| Total operating expenses | $257.19 | $433.71 | $305.78 | $311.16 |
| Operating income | $10.03 | -$48.1 | $11.36 | $11.59 |
| Income from continuing operations | ||||
| EBIT | $10.03 | -$48.1 | $11.36 | $11.59 |
| Income tax expense | $4.04 | $11.02 | -$0.67 | -$1.18 |
| Interest expense | -$8.15 | -$5.96 | -$5.51 | -$9.92 |
| Net income | ||||
| Net income | $9.3 | $129.13 | $4.62 | $0.97 |
| Income (for common shares) | $9.3 | $129.13 | $4.62 | $0.97 |
| (in millions $) | 30 Mar 2020 | 30 Mar 2019 | 30 Mar 2018 | 30 Mar 2017 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1334.98 | $1518.78 | $1250.05 | $1338.75 |
| Cost of revenue | $803.32 | $905.58 | $707.33 | $760.53 |
| Gross Profit | $531.66 | $613.2 | $542.72 | $578.22 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $278.66 | $276.05 | $293.56 | $309.86 |
| Total operating expenses | $1349.4 | $1447.89 | $1368.91 | $1381.48 |
| Operating income | -$14.41 | $70.89 | -$118.86 | -$42.73 |
| Income from continuing operations | ||||
| EBIT | -$14.41 | $70.89 | -$118.86 | -$42.73 |
| Income tax expense | $8.78 | $39.67 | $66.9 | $46.08 |
| Interest expense | -$30.64 | -$32.17 | -$32.92 | -$46.44 |
| Net income | ||||
| Net income | $140.62 | $42.49 | $12.77 | -$182.26 |
| Income (for common shares) | $140.62 | $42.49 | $12.77 | -$182.26 |
| (in millions $) | 29 Jun 2020 | 30 Mar 2020 | 30 Dec 2019 | 29 Sep 2019 |
|---|---|---|---|---|
| Net income | $9.3 | $129.13 | $4.62 | $0.97 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 30 Mar 2020 | 30 Mar 2019 | 30 Mar 2018 | 30 Mar 2017 |
|---|---|---|---|---|
| Net income | $140.62 | $42.49 | $12.77 | -$182.26 |
| Operating activities | ||||
| Depreciation | $25.33 | $20.42 | $20.13 | $41.64 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$68.79 | $188.03 | -$73.93 | $53.98 |
| Investing activities | ||||
| Capital expenditures | -$38.15 | -$103.9 | -$115.5 | -$50.72 |
| Investments | -$100.86 | -$15.8 | -$7.45 | -$4.17 |
| Total cash flows from investing | $168.88 | -$92.46 | $175.81 | -$33.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$108.53 | -$29.61 | $10.28 | -$15.51 |
| Total cash flows from financing | -$142.16 | -$60.69 | -$20.86 | -$62.63 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$42.07 | $34.88 | $81.01 | -$41.72 |
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $1.29B |
|---|---|
| EBITDA | N/A |
| EBIT | -$15.13M |
| Net Income | $144.03M |
| Revenue Q/Q | -13.66% |
| Revenue Y/Y | 14.59% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | 38.03% |
| Debt/Equity | 3.17 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |